Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281684
Status:
COMPLETED
Last Update Posted:
2019-01-28
First Post:
2006-01-23
Brief Title:
SB-705498 Dental Pain Study After Tooth Extraction
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Multi-centre Randomised Single Blind Placebo Controlled Parallel Group Study to Examine the Effect of Single Doses of SB-705498 a TRPV1 Receptor Antagonist on Pain Following Third Molar Tooth Extraction
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is a multi centre randomised single-blind parallel group placebo-controlled single oral dose study with a positive control arm Patients previously scheduled for 3rd molar tooth extraction who are otherwise healthy will be recruited Upon completion of surgery eg prior to established pain patients will be randomised to treatment SB-706598 placebo or co-codamol and dosed with the study medication
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None